Ictammolo Sella

Ichthammol, the active ingredient in Ictammolo Sella, is a topical anti‑inflammatory and keratolytic presented as a topical preparation for external use. It is applied to the skin to help manage inflammatory dermatoses, minor infections and wound healing in adults and children.

GNH USA supplies Ictammolo Sella as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for export to multiple regions. Customers benefit from reliable delivery schedules and post‑sale technical support.

Ichthammol is a topical anti‑inflammatory and keratolytic agent used in various dermatologic conditions.

- Acne: reduces inflammation, promotes drying of lesions and supports healing of pustular lesions. - Boils and furuncles: helps draw out pus, decreases swelling and accelerates resolution of localized skin infections. - Eczema and dermatitis: soothes itching, calms redness and assists in restoring skin barrier function. - Psoriasis plaques: softens scales, eases discomfort and aids in the gradual clearance of hyperkeratotic lesions.

Topical application of ichthammol may be associated with local skin reactions and, rarely, systemic adverse events.

Common Side Effects: - Skin irritation: mild redness or burning at the application site. - Dryness: localized skin dryness or flaking. - Pruritus: transient itching following application. - Erythema: temporary redness of the treated area. - Contact dermatitis: mild allergic skin reaction. - Stinging sensation: brief sharp feeling after application.

Serious or Rare Side Effects: - Severe allergic reaction: hives, swelling or anaphylaxis. - Skin necrosis: localized tissue death in extreme cases. - Systemic toxicity: rare absorption leading to gastrointestinal upset. - Phototoxicity: increased sensitivity to sunlight causing rash. - Hyperpigmentation: persistent darkening of the skin at the site. - Severe infection: secondary bacterial infection of the lesion.

When using ichthammol topical products, observe the following precautions to minimise risk and ensure effectiveness.

- Application area: apply only to intact skin unless directed by a healthcare professional. - Allergy assessment: discontinue use if signs of allergic contact dermatitis appear. - Age considerations: use with caution in children under two years of age. - Pregnancy and lactation: consult a physician before use during pregnancy or breastfeeding. - Concomitant topicals: avoid simultaneous use with other irritant or drying agents. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Ichthammol may interact with other topical agents, affecting skin tolerance or therapeutic outcomes.

Major Interactions (Avoid): - Potent corticosteroids: combined use can increase risk of skin thinning and atrophy. - Other keratolytics (e.g., salicylic acid): may cause excessive irritation or peeling.

Moderate Interactions (Monitor Closely): - Antibiotic ointments: may alter local absorption and efficacy. - Phototherapy: ichthammol can heighten photosensitivity, requiring sun protection. - Systemic retinoids: concurrent use may exacerbate skin irritation. - Antifungal creams: potential for reduced antifungal activity when mixed.